Biocon Limited — Board Meeting, 07-05-2026: Outcome of Board Meeting

Biocon's board approved Q4/FY26 consolidated results (Profit FY26: ₹1,429.4 Cr; Q4: ₹198.6 Cr). It proposed a final dividend of ₹0.50/share. Also greenlit acquiring remaining ~2% of Biocon Biologics for ₹330.73 Cr via share swap, aiming for ~99.99% ownership. New auditors & several directors appointed for unified growth.